Invega Tablet, Extended Release
Product Images NDC 50458-550

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Invega (NDC 50458-550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Invega 01)

Chemical structure of paliperidone, the active ingredient in INVEGA extended-release tablets. The diagram depicts the molecular arrangement and bonding pattern characteristic of paliperidone.*

FDA Label Image

Principal Display Panel (3 mg Tablet Bottle Label)

INVEGA paliperidone extended-release tablets, 3 mg strength, oral tablet form, in a package containing 30 tablets. The label includes instructions to swallow tablets whole and not to divide, crush, or chew them. It is manufactured by Janssen Pharmaceuticals, Inc. and is marked Rx only.*

FDA Label Image

Principal Display Panel (6 mg Tablet Bottle Label)

INVEGA 6 mg extended-release tablets label for oral use by Janssen Pharmaceuticals, Inc. The label specifies the product name and strength in large print, noting that the tablets should be swallowed whole and not divided, crushed, or chewed. It indicates prescription use only with a package size of 30 tablets.*

FDA Label Image

Principal Display Panel (9 mg Tablet Bottle Label)

INVEGA 9 mg Extended-Release Tablets packaging label showing paliperidone as the active ingredient in tablet, extended-release form. The label indicates the product is a prescription drug with 30 tablets per package, from Janssen Pharmaceuticals. Instructions note tablets should be swallowed whole without dividing, crushing, or chewing.*

FDA Label Image

Principal Display Panel (1.5 mg Tablet Bottle Label)

Label for INVEGA paliperidone Extended-Release Tablets, 1.5 mg strength. The oral tablet package contains 30 tablets and is labeled for prescription use only (Rx only). The label includes manufacturer's information: Janssen Pharmaceuticals, Inc., and features an NDC number 50458-554-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.